INDOBORAXNSEIndo Borax & Chemicals Limited· Chemicals & PetrochemicalsHighNeutral
Announced Wed, 25 Feb, 2026 · 12:52 IST

Indo Borax & Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 25, 2026.

INDOBORAX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.6%Reaction day
₹243.52
prior close
₹244.99
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+0.4% vs market
Commodity Chemicals peers, median of 49sector-0.2%+0.8% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.8 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
+0.0
15m
-0.2
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.6+0.2+0.4-0.2+0.8
Next day
+0.2+0.4-0.2-0.1+0.3
2d
+0.5-0.6+1.2-0.1+0.6
3d
+1.8-2.8+4.7-1.6+3.5
4d
+0.2-5.4+5.6-4.1+4.3
5d
+0.2-4.4+4.6-2.2+2.4
1w
+0.2-7.1+7.3-6.1+6.3
15d
+0.3-7.8+8.1-8.1+8.3
1m
+0.6-6.6+7.2-8.3+8.9
2m
+3.1+7.7-4.6+5.9-2.9
3m
+37.2+10.3+26.9+9.2+27.9
UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 49Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indo Borax & Chemicals Limited's Board of Directors met on February 25, 2026 and approved the appointment of Mr. Shashikant Bharuka as the new Chief Financial Officer (Key Managerial Personnel) effective March 06, 2026. Mr. Bharuka is a qualified Chartered Accountant and Company Secretary with over 24 years of post-qualification experience in finance and accounts. He has previously worked at Lupin Limited, Unichem Laboratories Limited, Ajanta Pharma, and IPCA Laboratories. The Board also approved a draft Postal Ballot Notice seeking shareholder approval for the proposed resolutions, which will be sent to shareholders shortly.

Likely market impact

The appointment of an experienced CFO from reputed listed pharma companies like Lupin and Unichem may be viewed positively by investors as it strengthens the company's finance leadership. Shareholders will get a chance to vote on related resolutions through the postal ballot process.